Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
117.00
0.00 (0.00%)
At close: Feb 4, 2026
51.95%
Market Cap427.27B +53.9%
Revenue (ttm)263.07B -11.2%
Net Income42.47B -15.5%
EPS11.63 -15.7%
Shares Out3.65B
PE Ratio10.06
Forward PEn/a
Dividend14.20 (12.14%)
Ex-Dividend DateNov 21, 2025
Volume4,000
Average Volume4,744
Openn/a
Previous Close117.00
Day's Range117.00 - 117.00
52-Week Range66.81 - 120.00
Beta-0.12
RSI77.46
Earnings DateFeb 9, 2026

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In fiscal year 2025, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements